Prot #Vedolizumab-4033: ENTYVIO(R) Long-Term Real-World Outcomes in Bio-naïve Ulcerative Colitis and Crohn's Disease Patients in Canada and the US: An EVOLVE Observational Follow-up Study

Bellaguarda, Emanuelle Araujo Lima (PD/PI)

Medicine, Gastroenterology Division

Project: Research project

Status	Active
Effective start/end date	11/1/22 → 11/1/25

Funding

PPD Investigator Services, LLC ((OE) Prot #Vedolizumab-4033 // (OE) Prot #Vedolizumab-4033)
Takeda Development Center Americas, Inc. ((OE) Prot #Vedolizumab-4033 // (OE) Prot #Vedolizumab-4033)